CLINICAL_TRIALS
trial_result
· 2011-02-11
Clinical Trial Update: Single Ascending Dose (BMS-813160) Study [Phase 1]
Summary
Phase 1 single ascending dose study of BMS-813160 in accelerated intimal hyperplasia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Accelerated Intimal Hyperplasia | Phase 1 | Status: COMPLETED